by
Endobronchial ultrasound biopsy (EBUS) is a minimally invasive medical procedure that allows physicians to examine and obtain samples from lymph nodes and tissues surrounding the trachea and bronchi. Using specialized scopes and ultrasound technologies, EBUS provides real-time images that help physicians accurately guide tiny sampling needles to suspicious lesions or lymph nodes. This allows samples to be obtained without surgery and provides critical diagnostic information to help determine treatment plans. In this article, we will explore what EBUS is, how it works, who benefits from it, and the role it plays in diagnosing and staging lung cancer and other conditions.
How EBUS Works
During an EBUS procedure, patients are sedated with mild anesthetics to help them remain comfortable. A thin, flexible endoscope called a bronchoscope is then inserted through the mouth or nose and guided down into the airways. Attached to the end of the bronchoscope is a miniature ultrasound probe that transmits high-frequency sound waves and uses the echoes to produce real-time images of the layers of tissue and structures surrounding the airways. These images clearly show lymph nodes, tumors, and other abnormalities.
Using these ultrasound images for guidance, the physician can precisely navigate very thin hollow needles through the working channel of the bronchoscope. Tiny tissue or cell samples can then be collected from affected lymph nodes or lesions by gently inserting the needle and removing the core tissue samples. The whole procedure only takes 30-60 minutes to perform and is usually well-tolerated even by frail patients. Patients can usually resume their normal activities the next day after monitoring.
Diagnosing and Staging Lung Cancer
One of the main uses of Endobronchial Ultrasound Biopsy is in the diagnosis and staging of lung cancers. Up to 30% of lung cancers are centrally located in the main airways or near large blood vessels. EBUS allows physicians to collect samples from these lesions without surgery and see if the cancer has spread to nearby lymph nodes.
Obtaining a definite tissue diagnosis is crucial for establishing the type and aggressiveness of the cancer. Sampling lymph nodes also helps determine the stage or extent of spread. This staging information is critical for determining the appropriate treatment options which may include surgery, chemotherapy, radiation therapy or combinations. EBUS has a high rate of success, with studies finding cancers detected in over 90% of cases where a tissue sample is taken.
Detecting Other Conditions
While a valuable tool for lung cancer, EBUS is also useful for diagnosing other chest conditions affecting the lungs and surrounding structures. It helps obtain tissue samples when infections, inflammation or masses are seen pressing on the airways on CT scans or chest x-rays but their exact nature needs to be determined. Examples include sampling enlarged lymph nodes to check for tuberculosis or fungal infections, or abnormal growths in the area to diagnose sarcoidosis or other rare diseases.
EBUS also monitors treatment response in these conditions. Regular follow-up procedures after chemotherapy or therapies for lung infections can help physicians track if lesions are shrinking with treatment or if new areas have been affected. This type of sequential sampling is less invasive than repeat surgical biopsies and better informs treatment decisions.
Benefits vs Traditional Methods
Compared to alternative biopsy methods, EBUS offers several advantages. Standard bronchoscopy alone cannot reliably sample lymph nodes beyond the directly visible airway walls. CT or ultrasound-guided needle biopsies also have limitations as they cannot ensure the exact node or lesion is targeted, and multiple biopsies increase risks.
On the other hand, EBUS provides real-time ultrasound images of the target area along with information on its distance from important structures. This helps physicians precisely navigate specially designed biopsy needles to the right location under direct vision. It avoids unnecessary multiple passes, reduces complications and makes the yield from each sample significantly higher.
The minimal invasiveness of EBUS also makes it safer for elderly or seriously ill patients who may not be strong enough to tolerate an invasive surgical procedure. Additionally, EBUS can sample multiple different lymph node stations or lesions in one setting to provide a more comprehensive evaluation than other methods
Endobronchial ultrasound biopsy has emerged as an invaluable tool that has transformed the diagnosis and staging of lung cancers and other chest diseases. Its ability to safely obtain high-yield diagnostic samples from hard to reach lung structures under real-time imaging guidance provides crucial information. This helps physicians determine the most effective treatments while avoiding unnecessary invasive procedures. With benefits of precision, safety and comprehensive sampling, EBUS continues to grow in its use worldwide as the investigation of choice for pulmonary lesions and mediastinal lymphadenopathy.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
